FGFR1 and hypophosphatemia: We used CRISPR/Cas9 technology to generate a knock-in mouse model expressing the disease-causing FGFR1 variant, p.N330I (Figure 1A), chosen because of its frequency and its association with FGF23 excess and hypophosphatemia in patients.